Unbiased Analysis of Today's Healthcare Issues
No, this is not coming nation-wide, but it may be on its way in California. Kaiser Health News reports: A provision in California’s newly approved state budget will eliminate the asset test for the 2 million Californians enrolled in both Medi-Cal and Medicare, the federal health insurance program for people 65 and older and people…
Taking a break today from my normal health economics posting to celebrate my hometown Milwaukee Bucks winning the NBA Championship. What an amazing playoff run! The Sun block… And the alley oop!
$2.2 trillion deficit in 2021. Adverse selection and ACA plans. COVID-19 and panic drug purchasing. Amazon: $6 six-month prescriptions Pharmacist’s opinion on value-based comprehensive medication management
Last Friday, President Biden released an executive order titled “Promoting Competition in the American Economy” While the order talk about transportation, internet companies, and farming, there were a number of provisions related to health care. I summarize each of these below. Specifically I review OTC hearing aids. Currently, many patients need to visit a doctor…
Administrative simplicity vs. single payer. 340B case heads to the Supreme Court. Marketing and mammograms NY ends state of emergency: what happens to out-of-state licensed health care professionals? Key facts on the Delta Variant.
A few updates on COVID-19 from where I am living. First while we see a dramatic decline in COVID-19 infections and deaths, there is a fair amount of regional variation within California. The Sacramento Bee reports that: The average number of new COVID infections reported each day dropped by an astounding 98% from December to…
Evaluating the robustness of CMS Hospital VBP measurement system. ICER’s gene therapy evaluations. Who are high-frequency hospital users? EHR and malpractice. What is Evio? Has in vivo gene editing come of age?
Why the FDA approved aducanumab. How to report changes in clinical trial protocols due to COVID-19 (CONSERVE) Democrats eye Medicare and Medicaid expansions. ACA and biosimilars. The challenges of improving quality of care. Native Americans and health equity.
Supreme court upholds ACA. Nature on lab-leak hypothesis. The geography of global warming. The return of boarding houses. Business perspective on single payer.
A decade of value-based payment. What caused him to resign from an expert panel. In case you missed it. Do physicians have an “ethical and legal duty” to reinterpret genetic test results? What to do when MCMC fails? Medicare drug price negotiations back on the table?